文章摘要
尚沛津,窦 芳,张一恺,刘天龙,刘文星,许 航,牟 菲,李玉文,文爱东.11-羰基-β-乙酰乳香酸抑制自发性高血压大鼠血管重构研究[J].,2017,17(8):1405-1410
11-羰基-β-乙酰乳香酸抑制自发性高血压大鼠血管重构研究
Research of Acetyl-11-keto-β-boswellic Acid on Vascular Remodeling of Spontaneously Hypertensive Rats
投稿时间:2016-08-18  修订日期:2016-09-10
DOI:10.13241/j.cnki.pmb.2017.08.002
中文关键词: 11-羰基-β-乙酰乳香  高血压  血管重构
英文关键词: Acetyl-11-keto-β-boswellic acid  Hypertension  Vascular remodeling
基金项目:国家自然科学基金项目(81201985;81373947)
作者单位E-mail
尚沛津 第四军医大学西京医院药剂科 陕西 西安 710032中国人民解放军第517医院药剂科 山西 忻州 034000 306318199@qq.com 
窦 芳 第四军医大学西京医院药剂科 陕西 西安 710032  
张一恺 沈阳军区总医院药剂科 辽宁 沈阳 110016  
刘天龙 第四军医大学西京医院药剂科 陕西 西安 710032  
刘文星 第四军医大学西京医院药剂科 陕西 西安 710032  
许 航 第四军医大学西京医院药剂科 陕西 西安 710032  
牟 菲 第四军医大学西京医院药剂科 陕西 西安 710032  
李玉文 第四军医大学西京医院药剂科 陕西 西安 710032  
文爱东 第四军医大学西京医院药剂科 陕西 西安 710032  
摘要点击次数: 284
全文下载次数: 167
中文摘要:
      摘要 目的:观察11-羰基-β-乙酰乳香酸(AKBA)对高血压血管重构的抑制作用。方法:自发性高血压大鼠(SHR)随机分为模型组(SHR),20 mg/kg AKBA低剂量组(AKBA-L),40 mg/kg AKBA高剂量组(AKBA-H)和20 mg/kg替米沙坦组(Telmi),另设Wistar-Kyoto(WKY)空白对照组。各组大鼠分别灌胃给予8周相应药物和蒸馏水。每周监测大鼠收缩压;检测大鼠血液一氧化氮(NO)和血管紧张素II(AngII)水平;评估整体炎性反应和氧化应激水平;苏木精-伊红染色观察血管重构情况;马森染色观察血管胶原沉积情况。结果:8周给药期间,SHR血压持续升高,替米沙坦显著降低血压,但AKBA未显示出明显的血压调节作用。与SHR组相比,AKBA和替米沙坦都有效地减少了血管压力,减少AngII分泌,增加NO的产生(P<0.05);其次有效地降低炎性反应和氧化应激,显著改善机体肿瘤坏死因子-α(TNF-α)、单核细胞趋化蛋白-1(MCP-1)、过氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)和丙二醛(MDA)的表达水平(P<0.05)。除此之外,相比SHR组,AKBA显著抑制血管重构,降低血管厚度,横切面积和血管厚度/血管内径比值(P<0.05),减少血管胶原沉积(P<0.05)。结论:AKBA能有效缓解血管压力和氧化应激,减少胶原沉积,从而有效改善血管重构。
英文摘要:
      ABSTRACT Objective: To observe the inhibitory effect of Acetyl-11-keto-β-boswellic acid (AKBA) on vascular remodeling of spontaneously hypertensive rats. Methods: Spontaneously hypertensive rats (SHR) were randomly divided into four groups as follow: the model group (SHR), 20 mg/kg AKBA group (AKBA-L), 40 mg/kg (AKBA-H) and 20 mg/kg telmisartan group (Telmi), in addition, age-matched Wistar-Kyoto rats (WKY) were needed as contrast. Each group was treated by orally gavage with corresponding drugs and water for 8 weeks. Systolic blood pressure was monitored weekly, and vascular contractility was assessed by nitric oxide (NO) and angiotensin II(AngII)secretion, additionally, systemic inflammatory response and oxidative stress were preliminarily evaluated. Hematoxylin & eosin staining was used to assess vascular morphological alterations, and Masson staining was used to evaluate collagen deposition. Results: Systolic blood pressure of SHR was continuously elevated during 8 w, and AKBA showed no effect on systolic blood pressure. Whereas, AKBA decreased vascular contractility notably through restoring NO and AngII levels (P<0.05). Further, AKBA decreased inflammatory response and oxidative stress by restoring tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1), superoxide dismutase (SOD), glutathione peroxidase (GPx) and malondialdehyde (MDA) levels significantly (P<0.05). AKBA markedly decreased vascular remodeling, decreased vascular wall thickness, vascular cross-sectional area and media/lumen ratio (P<0.05), which were significantly elevated in SHR group. Additionally, AKBA effectively decreased collagen deposition in vascular walls of hypertension. Conclusion: AKBA can effectively decrease vascular contractility and attenuate oxidative stress, and thus decrease collagen deposition and attenuate vascular remodeling.
查看全文   查看/发表评论  下载PDF阅读器
关闭